Aimee L. Hoyt net worth and biography

Aimee Hoyt Biography and Net Worth

SVP of Illumina
Aimee L. Hoyt is the Senior Vice President and Chief People Officer of Illumina, Inc, effective January 8, 2018. Ms. Hoyt has held senior positions at some of the world's best-known technology companies including Hewlett-Packard, Cisco and Sun Microsystems. Most recently, she was the Chief Human Resources Officer at Rackspace, a leading managed cloud computing company, in San Antonio, Texas. She led the HR team and was responsible for helping build, align and develop high-performing global teams. During her tenure, Rackspace was recognized as one of Fortune's 100 Best Companies to Work For, Top 30 Best Places in Tech and Great Places to Work for Millennials. Ms. Hoyt earned a master's in human resource development from the Rochester Institute of Technology.

What is Aimee L. Hoyt's net worth?

The estimated net worth of Aimee L. Hoyt is at least $1.02 million as of April 12th, 2022. Ms. Hoyt owns 5,342 shares of Illumina stock worth more than $1,019,200 as of October 1st. This net worth approximation does not reflect any other assets that Ms. Hoyt may own. Learn More about Aimee L. Hoyt's net worth.

How do I contact Aimee L. Hoyt?

The corporate mailing address for Ms. Hoyt and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected] Learn More on Aimee L. Hoyt's contact information.

Has Aimee L. Hoyt been buying or selling shares of Illumina?

Aimee L. Hoyt has not been actively trading shares of Illumina during the last quarter. Most recently, Aimee L. Hoyt sold 2,474 shares of the business's stock in a transaction on Tuesday, April 12th. The shares were sold at an average price of $350.51, for a transaction totalling $867,161.74. Following the completion of the sale, the senior vice president now directly owns 5,342 shares of the company's stock, valued at $1,872,424.42. Learn More on Aimee L. Hoyt's trading history.

Who are Illumina's active insiders?

Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.

Are insiders buying or selling shares of Illumina?

In the last year, insiders at the life sciences company sold shares 19 times. They sold a total of 21,102 shares worth more than $8,202,908.23. The most recent insider tranaction occured on July, 7th when SVP Alexander Aravanis sold 539 shares worth more than $107,800.00. Insiders at Illumina own 0.1 % of the company. Learn More about insider trades at Illumina.

Information on this page was last updated on 7/7/2022.

Aimee L. Hoyt Insider Trading History at Illumina

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/12/2022Sell2,474$350.51$867,161.745,342View SEC Filing Icon  
6/24/2021Sell500$475.00$237,500.00View SEC Filing Icon  
4/5/2021Sell1,000$386.03$386,030.00View SEC Filing Icon  
1/11/2021Sell271$379.65$102,885.152,630View SEC Filing Icon  
12/14/2020Sell354$345.00$122,130.002,744View SEC Filing Icon  
11/6/2020Sell215$310.10$66,671.503,313View SEC Filing Icon  
6/8/2020Sell191$350.94$67,029.543,498View SEC Filing Icon  
3/5/2020Sell417$273.95$114,237.153,689View SEC Filing Icon  
2/26/2019Sell298$304.63$90,779.742,297View SEC Filing Icon  
See Full Table

Aimee L. Hoyt Buying and Selling Activity at Illumina

This chart shows Aimee L Hoyt's buying and selling at Illumina by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Illumina Company Overview

Illumina logo
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Read More

Today's Range

Now: $190.79
Low: $183.65
High: $194.22

50 Day Range

MA: $206.33
Low: $184.12
High: $227.44

2 Week Range

Now: $190.79
Low: $173.45
High: $428.00

Volume

2,775,675 shs

Average Volume

1,292,445 shs

Market Capitalization

$29.97 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16